“Sofpironium Targets M3 Receptors In Vitro and Shows Early Clinically Meaningful Improvement in Primary Axillary Hyperhidrosis Symptoms” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s717. doi:10.25251/kvstvq23.